Author: Patricia R. Blanco

Winnie Byanyima, the executive director of UNAIDS, envisions the end of the AIDS pandemic by 2030. To achieve this goal, a breakthrough antiviral drug called lenacapavir must become accessible to at-risk populations. Developed by Gilead, this drug boasts impressive efficacy rates but remains out of reach due to its high cost. Byanyima, a champion of social justice and gender equality, recently visited Spain to advocate for universal healthcare. During an interview in Madrid, she emphasized how gender inequality contributes to new HIV infections, particularly among young women in sub-Saharan African countries. Lenacapavir has the potential to revolutionize HIV prevention and…